# ![@TonixPharma Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::374071770.png) @TonixPharma Tonix Pharmaceuticals

Tonix Pharmaceuticals posts on X about $tnxp, ceo, biotech, pain the most. They currently have [-----] followers and [--] posts still getting attention that total [---] engagements in the last [--] hours.

### Engagements: [---] [#](/creator/twitter::374071770/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::374071770/c:line/m:interactions.svg)


### Mentions: [--] [#](/creator/twitter::374071770/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::374071770/c:line/m:posts_active.svg)


### Followers: [-----] [#](/creator/twitter::374071770/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::374071770/c:line/m:followers.svg)


### CreatorRank: undefined [#](/creator/twitter::374071770/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::374071770/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[finance](/list/finance)  [countries](/list/countries)  [travel destinations](/list/travel-destinations)  [luxury brands](/list/luxury-brands)  [stocks](/list/stocks) 

**Social topic influence**
[$tnxp](/topic/$tnxp), [ceo](/topic/ceo), [biotech](/topic/biotech), [pain](/topic/pain), [dr](/topic/dr), [a new](/topic/a-new), [focused](/topic/focused), [sleep](/topic/sleep), [barcelona](/topic/barcelona), [spain](/topic/spain)

**Top assets mentioned**
[GARY (GARY)](/topic/gary) [Msci Inc (MSCI)](/topic/msci-inc)
### Top Social Posts
Top posts by engagements in the last [--] hours

"Last week $TNXP presented a poster presentation at the 66th Annual AHS Meeting: It is hoped that non-oral medicines will address some of the persistent dissatisfaction patients experience with their migraine treatments said @SethLederman CEO"  
[X Link](https://x.com/TonixPharma/status/1803812795026157776)  2024-06-20T15:30Z [----] followers, [---] engagements


"$TNXP to participate in the [----] BIO CEO & Investor Conference with a presentation on February [--] [----] at 1:45 p.m. ET in NYC. Read more about the conference and company presentation here: https://bit.ly/3Q4f2nI https://bit.ly/3Q4f2nI"  
[X Link](https://x.com/TonixPharma/status/1887254676216701144)  2025-02-05T21:39Z [----] followers, [----] engagements


"Progress happens faster when patients and science move together. In a new op-ed Tonix CEO Dr. Seth Lederman shares how patient experiences inspired innovation in chronic pain leading to the first new fibromyalgia therapy in adults in over [--] years. #Fibromyalgia #ChronicPain #Innovation #TonixPharma http://bit.ly/47oLppC http://bit.ly/47oLppC http://bit.ly/47oLppC http://bit.ly/47oLppC"  
[X Link](https://x.com/TonixPharma/status/1983244218635022382)  2025-10-28T18:47Z [----] followers, [---] engagements


"@TonixPharma will present at BIO-Europe [----] taking place November [--] in Vienna Austria. Seth Lederman M.D. Chief Executive Officer will present on Tuesday November [--] highlighting Tonixs strategy pipeline and upcoming milestones"  
[X Link](https://x.com/TonixPharma/status/1983560811432800336)  2025-10-29T15:45Z [----] followers, [----] engagements


"@TonixPharma has just licensed a novel compound from Rutgers University that is designed to treat chronic neuropathic pain. TNX-4900 advances research into non-opioid solutions for chronic pain. The new program reinforces Tonixs commitment to investigating potential new therapies for patients suffering from debilitating pain conditions. Read more here: https://bit.ly/44xsMPI https://bit.ly/44xsMPI"  
[X Link](https://x.com/anyuser/status/2000951776061628544)  2025-12-16T15:30Z [----] followers, [---] engagements


"Regulatory modernization will be a defining factor for biopharma in [----]. In PharmaVoices Crystal Ball feature @TonixPharma CEO Dr. Seth Lederman discusses how smarter review pathways and real-world evidence can help move meaningful therapies forward more efficiently. Thank you to @PharmaVoice and @MeaganParrish for the opportunity to contribute. 🔗 #FDA #Biotech #LifeSciences #Innovation https://www.pharmavoice.com/news/pharma-crystal-ball-2026-predictions-regulations-policy-market/808688/ https://www.pharmavoice.com/news/pharma-crystal-ball-2026-predictions-regulations-policy-market/808688/"  
[X Link](https://x.com/anyuser/status/2009611149453447536)  2026-01-09T13:00Z [----] followers, [---] engagements


"Tonix Pharmaceuticals has opened a new larger corporate headquarters in Berkeley Heights NJ reinforcing our long-term commitment as a commercial-stage biotech company focused on CNS and immunology therapies. Learn more: #Biotechnology #LifeSciences #CommercialStage #NewJersey http://www.tonixpharma.com http://www.tonixpharma.com"  
[X Link](https://x.com/anyuser/status/2019468540428845455)  2026-02-05T17:49Z [----] followers, [----] engagements


"#MichaelJackson's death wasnt just a tragedy it was a failure of how medicine treats chronic pain and sleep disorders. In RealClear Health our CEO @SethLederman examines fibromyalgia fragmented care and why symptom-chasing with risky drugs still persists today. We know better now. Care must change. More essays and reflections are available on Seths Substack: #ChronicPain #Fibromyalgia #SleepHealth #PainScience #NonOpioidCare #Tonix Read article: http://bit.ly/4qWynYR http://bit.ly/4rAbhr3 http://bit.ly/4qWynYR http://bit.ly/4rAbhr3"  
[X Link](https://x.com/anyuser/status/2019468407020699725)  2026-02-05T17:49Z [----] followers, [----] engagements


"Maine is facing record Lyme disease cases and new prevention strategies are urgently needed. @newscentermaine featured Tonixs work on a long-acting antibody approach to Lyme prevention with expert insights from CEO @SethLederman. Thank you to @vivienleigh6 for covering this important topic Read more: #LymeDisease #PublicHealth #Biotech https://www.newscentermaine.com/article/news/health/tick-and-lyme/maine-faces-record-lyme-cases-new-antibody-shot-offer-protection-by-2029/97-db405270-3509-472d-89c9-c34327c4a609"  
[X Link](https://x.com/anyuser/status/2021621562441371926)  2026-02-11T16:25Z [----] followers, [---] engagements


"Today $TNXP announced that Gregory Sullivan M.D. CMO will present a poster detailing $TNXP's #MDD programs at the [----] ASCP Annual Meeting on June 1st at the Loews Miami Beach Hotel in Miami Beach FL. #ASCP2023 Details here:"  
[X Link](https://x.com/TonixPharma/status/1661785346261102602)  2023-05-25T17:24Z [----] followers, [--] engagements


"(Trade Alert Tonix Pharmaceuticals (OTCBB: TNXP) @ Bio CEO conference Waldorf Astoria NYC http://t.co/8RoA8yAs #biotech #FDA #bioceo http://bit.ly/xnf8Ja http://bit.ly/xnf8Ja"  
[X Link](https://x.com/TonixPharma/status/166915320576086016)  2012-02-07T16:04Z [----] followers, [--] engagements


"Today $TNXP announced the 1st participant was enrolled in investigator-initiated Ph [--] POWER study of TNX-1900 (intranasal potentiated oxytocin) for the treatment of pediatric #obesity at the Massachusetts General Hospital (@MassGeneralNews). The study will investigate the"  
[X Link](https://x.com/TonixPharma/status/1678458168408506368)  2023-07-10T17:39Z [----] followers, [---] engagements


"$TNXP announced it received an official response from pre-IND meeting w/ FDA to develop TNX-801 to protect against #mpox & #smallpox. $TNXP believes the feedback provides path to agreement on design of Ph 1/2 study & overall clinical development plan https://bit.ly/45zqnSA https://bit.ly/45zqnSA"  
[X Link](https://x.com/TonixPharma/status/1694004609222946975)  2023-08-22T15:12Z [----] followers, [---] engagements


"Today $TNXP announced a poster presentation at the Seventh International Cancer Immunotherapy Conference #CICON23. The Conference is being held September 20-23 [----] in Milan Italy"  
[X Link](https://x.com/TonixPharma/status/1702429328242577672)  2023-09-14T21:09Z [----] followers, [---] engagements


"Today $TNXP announced that the @UNC Institute for Trauma Recovery has been awarded a $3M grant from @DeptofDefense to investigate the potential of $TNXPs TNX-102 SL (to reduce the frequency and severity of adverse effects of acute trauma. Read more here:"  
[X Link](https://x.com/TonixPharma/status/1707091162270437461)  2023-09-27T17:53Z [----] followers, [----] engagements


"Yesterday $TNXP announced pricing of $4.5 million public offering. More here:"  
[X Link](https://x.com/TonixPharma/status/1707810915104575846)  2023-09-29T17:33Z [----] followers, [---] engagements


"Today $TNXP announced an upcoming presentation at the World Vaccine Congress Europe on Wednesday October [--] [----] at 2:45 p.m. CEST in Barcelona Spain"  
[X Link](https://x.com/TonixPharma/status/1712154174899560801)  2023-10-11T17:12Z [----] followers, [---] engagements


"Today $TNXP announced the completion of the clinical phase of Ph [--] potential registration-quality "UPLIFT" study of TNX-601 ER for major depressive disorder #MDD. Topline results are expected early November. More here:"  
[X Link](https://x.com/anyuser/status/1714000455225745448)  2023-10-16T19:28Z [--] followers, [----] engagements


"Today $TNXP announced that a study published in @Nature by faculty at the Center for Transplantation Sciences MGH (@MassGenNews) in collaboration w/ @eGenesisBIO utilized TNX-1500 (anti-CD40L mAb) as part of the immune modulating regimen to prevent organ transplant rejection"  
[X Link](https://x.com/TonixPharma/status/1714752409228956081)  2023-10-18T21:16Z [----] followers, [---] engagements


"TNX-1500 is in development for prevention of human kidney organ transplant rejection & is currently enrolling in a Ph [--] study. Press release: Nature article:"  
[X Link](https://x.com/anyuser/status/1714752410604732678)  2023-10-18T21:16Z [--] followers, [---] engagements


"Today $TNXP announced data from two presentations recently delivered at #ACS Clinical Congress & #IPITA-IXA-CTRMS Joint Congress involving Tonixs TNX-1500 which is currently in Ph [--] development for prevention of organ transplant rejection. More here:"  
[X Link](https://x.com/TonixPharma/status/1719007339020177443)  2023-10-30T15:04Z [----] followers, [---] engagements


"Today $TNXP announced highly statistically significant & clinically meaningful topline results in 2nd positive Ph [--] clinical trial of TNX-102 SL for the management of fibromyalgia"  
[X Link](https://x.com/TonixPharma/status/1737556215826116759)  2023-12-20T19:30Z [----] followers, [----] engagements


"Today $TNXP announced that @SethLederman CEO will present and host investor meetings at two upcoming investor conferences following positive topline results in 2nd pivotal Ph [--] trial of TNX-102 SL for the management of #fibromyalgia. More info here:"  
[X Link](https://x.com/TonixPharma/status/1742632652996247600)  2024-01-03T19:42Z [----] followers, [---] engagements


"Yesterday $TNXP announced that @SethLederman CEO will present at the BIO CEO & Investor Conference on February [--] [----]. #BIOCEO"  
[X Link](https://x.com/TonixPharma/status/1760325584326905980)  2024-02-21T15:28Z [----] followers, [---] engagements


"Today $TNXP announced additional efficacy data from the 2nd positive Ph [--] study of Tonmya (also known as TNX-102 SL) for the management of #fibromyalgia presented at the 6th International Congress on Controversies in Fibromyalgia in Brussels Belgium"  
[X Link](https://x.com/TonixPharma/status/1767253115424661839)  2024-03-11T18:15Z [----] followers, [---] engagements


"This week $TNXP announced financial results for 4Q & FY23 ended December [--] [----] and provided an overview of recent operational highlights. $TNXPs near-term focus is seeking U.S. marketing approval for Tonmya for the treatment of #fibromyalgia. https://bit.ly/49BhklX https://bit.ly/49BhklX"  
[X Link](https://x.com/TonixPharma/status/1776308514966720671)  2024-04-05T17:58Z [----] followers, [---] engagements


"Yesterday $TNXP presented new data from the Ph [--] RESILIENT trial of Tonmya (TNX-102 SL) for the management of #fibromyalgia in an oral presentation at the ASCP Annual Meeting suggesting activity for improvement in depressive symptoms"  
[X Link](https://x.com/TonixPharma/status/1798112138286026766)  2024-06-04T21:58Z [----] followers, [---] engagements


"$TNXP remains on track to submit an NDA to the FDA in 2H24 & has scheduled a Type B pre-NDA meeting w/ FDA for the 2Q24. Press release here: ASCP presentation here: https://bit.ly/3XdjwgV https://bit.ly/4c1Bw1O https://bit.ly/3XdjwgV https://bit.ly/4c1Bw1O"  
[X Link](https://x.com/TonixPharma/status/1798112140861296710)  2024-06-04T21:58Z [----] followers, [---] engagements


"Yesterday $TNXP announced a poster presentation at EULAR [----] being held June 12-15 [----] in Vienna Austria to highlight the statistically significant Ph [--] results of Tonmya (TNX-102 SL) for the management of #fibromyalgia.#EULAR2024 https://bit.ly/3Vw3cW7 https://bit.ly/3Vw3cW7"  
[X Link](https://x.com/TonixPharma/status/1798812314902077797)  2024-06-06T20:20Z [----] followers, [---] engagements


"Today $TNXP announced it has entered into a placement agency agreement for a public offering with expected gross proceeds of $4M which is expected to close on or about June [--] [----]. Details here: https://bit.ly/4bTMk2v https://bit.ly/4bTMk2v"  
[X Link](https://x.com/TonixPharma/status/1800948528635838921)  2024-06-12T17:49Z [----] followers, [----] engagements


"Last week on June 28th $TNXP announced the closing of its public offering. The gross proceeds are $4.0M before deducting placement agent fees and other estimated offering expenses payable by the Company. More here: https://bit.ly/3xF8xSS https://bit.ly/3xF8xSS"  
[X Link](https://x.com/TonixPharma/status/1808280769883701650)  2024-07-02T23:25Z [----] followers, [---] engagements


"Last week on July [--] $TNXP announced the closing of its public offering. The gross proceeds are $4.0M before deducting placement agent fees and other estimated offering expenses payable by the Company. More here: https://bit.ly/4eWQlVA https://bit.ly/4eWQlVA"  
[X Link](https://x.com/TonixPharma/status/1814287224831181002)  2024-07-19T13:12Z [----] followers, [---] engagements


"This week $TNXP announced the potential positive impact of the @theNASEM new definition of #LongCOVID on the size of the #fibromyalgia market for TNX-102 SL. NASEM cites FM as a diagnosable condition in people suffering from Long COVID"  
[X Link](https://x.com/TonixPharma/status/1819366239602360822)  2024-08-02T13:34Z [----] followers, [---] engagements


"Diagnosing fibromyalgia in Long COVID patients is expected to expand the potential addressable market for TNX-102 SL relative to pre-COVID-19 pandemic estimates. Read more here: https://bit.ly/3SyzgIa https://bit.ly/3SyzgIa"  
[X Link](https://x.com/TonixPharma/status/1819366241762504706)  2024-08-02T13:34Z [----] followers, [---] engagements


"Last week $TNXP presented a poster presentation at the @IASPpain [----] World Congress on Pain which highlighted data and analyses from the statistically significant Ph [--] RESLIENT study of TNX-102 SL for the management of #Fibromyalgia"  
[X Link](https://x.com/TonixPharma/status/1823304726009520517)  2024-08-13T10:24Z [----] followers, [---] engagements


"Today $TNXP reiterated its commitment to advance development of live virus vaccine TNX-801 for preventing #mpox & other infectious diseases. The @WHO announced that upsurge of mpox in Africa constitutes public health emergency of international concern. https://bit.ly/4dNvfYC https://bit.ly/4dNvfYC"  
[X Link](https://x.com/TonixPharma/status/1824478383926841359)  2024-08-16T16:08Z [----] followers, [----] engagements


"Today $TNXP announced it will deliver an oral presentation & present [--] posters at the [----] Military Health System Research Symposium (#MHSRS) being held August 26-29 [----] in Kissimmee FL. Details here: https://bit.ly/46TLGQO https://bit.ly/46TLGQO"  
[X Link](https://x.com/TonixPharma/status/1826272422087332000)  2024-08-21T14:57Z [----] followers, [----] engagements


"$TNXP announces appointment of Thomas Englese as Executive Vice President of Commercial Operations bringing over [--] years of commercial and operations experience in the biopharmaceutical industry to the company. Read more here: https://bit.ly/3B99u7d https://bit.ly/3B99u7d"  
[X Link](https://x.com/TonixPharma/status/1833503450383950079)  2024-09-10T13:51Z [----] followers, [----] engagements


"$TNXP announces issuance of an additional U.S. patent by the @USPTO covering intranasal delivery of Tosymra to treat migraines; expected to expire in [----]. Read more here: https://bit.ly/4e7NBE9 https://bit.ly/4e7NBE9"  
[X Link](https://x.com/TonixPharma/status/1836733749825851500)  2024-09-19T11:47Z [----] followers, [----] engagements


"White House Office of Pandemic Preparedness and Response Policy roundtable affirms the United States leadership role in the global mpox response identified efforts to bolster domestic preparedness and readiness for a clade [--] mpox case. Learn more here: https://bit.ly/4e5qPwF https://bit.ly/4e5qPwF"  
[X Link](https://x.com/TonixPharma/status/1836829967340163101)  2024-09-19T18:09Z [----] followers, [----] engagements


"$TNXP announces submission of New Drug Application to @US_FDA for TNX-102 SL for the management of #fibromyalgia; was previously granted Fast Track Designation. Read more here: https://bit.ly/4081luy https://bit.ly/4081luy"  
[X Link](https://x.com/TonixPharma/status/1846567396103917950)  2024-10-16T15:02Z [----] followers, [----] engagements


"$TNXP announces oral presentation at the World Vaccine Congress Europe [----] on Wednesday October [--] [----] in Barcelona Spain at 2:10 p.m. CET. Read more here: https://bit.ly/40iyHqA https://bit.ly/40iyHqA"  
[X Link](https://x.com/TonixPharma/status/1849859962782306737)  2024-10-25T17:05Z [----] followers, [----] engagements


"$TNXP will present at the [----] ThinkEquity Conference on Wednesday October [--] [----] at 9:30 a.m. ET at the Mandarin Oriental in New York City. The company will also host investor meetings. Read more here: https://bit.ly/48p4I2k https://bit.ly/48p4I2k"  
[X Link](https://x.com/TonixPharma/status/1849877932996501751)  2024-10-25T18:17Z [----] followers, [----] engagements


"$TNXP presented preclinical data on potential #mpox vaccine candidate TNX-801 at World Vaccine Congress-Europe [----] including positive tolerability data in animal models. Learn more here: https://bit.ly/3NVM3kV https://bit.ly/3NVM3kV"  
[X Link](https://x.com/TonixPharma/status/1853425318800871787)  2024-11-04T13:13Z [----] followers, [----] engagements


"$TNXP announces research agreement with @KEMRI_Kenya to design plan and seek regulatory approval for a Phase I clinical study of TNX-801 for #mpox in Kenya. Read more here: https://bit.ly/4evv4kq https://bit.ly/4evv4kq"  
[X Link](https://x.com/TonixPharma/status/1856409002542014965)  2024-11-12T18:49Z [----] followers, [----] engagements


"$TNXP announces poster presentation on TNX-102 SL for fibromyalgia at the American College of Rheumatology (ACR) Convergence [----] Annual Meeting on Sunday November [--] at 10:30 a.m. ET in Washington D.C. hosted by @ACRheum. Learn more here: https://bit.ly/48R7EF9 https://bit.ly/48R7EF9"  
[X Link](https://x.com/TonixPharma/status/1857057482675278076)  2024-11-14T13:46Z [----] followers, [----] engagements


"$TNXP presented data and analyses of TNX-102 SL treatment effects on fibromyalgia at the American College of Rheumatology (ACR) Convergence [----] Annual Meeting hosted by @ACRheum. Learn more here: https://bit.ly/4eyDlEf https://bit.ly/4eyDlEf"  
[X Link](https://x.com/TonixPharma/status/1858572631147975127)  2024-11-18T18:07Z [----] followers, [----] engagements


"$TNXP to participate in NobleCon20 @NobleCapMkts 20th Annual Emerging Growth Equity Conference being held December 3-4 in Boca Raton Fla. Jessica Morris Chief Operating Officer of $TNXP will present on Tuesday December [--] [----] at 12:00 p.m. ET. Learn more here: https://bit.ly/4fB1ATD https://bit.ly/4fB1ATD"  
[X Link](https://x.com/TonixPharma/status/1861434638360858911)  2024-11-26T15:39Z [----] followers, [----] engagements


"A video of $TNXP's presentation at NobleCon20 @NobleCapMkts 20th Annual Emerging Growth Equity Conference from Tuesday December [--] [----] is available for replay under the IR Events tab of the $TNXP website here: It is also available as part of a complete catalog of presentations available at the @NobleCapMkts Conference website at and on @channelchek the investor portal created by @NobleCapMkts at http://www.channelchek.com http://www.nobleconference.com https://bit.ly/3ZrLvZF https://bit.ly/3ZrLvZF http://www.channelchek.com http://www.nobleconference.com https://bit.ly/3ZrLvZF"  
[X Link](https://x.com/TonixPharma/status/1865078708329156936)  2024-12-06T16:59Z [----] followers, 12.1K engagements


"$TNXP announces @US_FDA acceptance of filing of New Drug Application for TNX-102 SL for #Fibromyalgia. @US_FDA is expected to assign a Prescription Drug User Fee Act (PDUFA) target action date and announce whether Priority Review has been granted in a Day [--] Letter. TNX-102 SL a non-opioid centrally acting analgesic granted Fast Track designation by @US_FDA has the potential to be the first member of a new class of analgesic drugs for fibromyalgia and the first new drug for treating fibromyalgia in more than [--] years if approved by @US_FDA. Learn more about the NDA acceptance here:"  
[X Link](https://x.com/TonixPharma/status/1869125878367887562)  2024-12-17T21:01Z [----] followers, 23.2K engagements


"Today $TNXP announced that the @US_FDA assigned a Prescription Drug User Fee Act (#PDUFA) goal date of Aug. 15th [----] for a decision on marketing approval for TNX-102 SL for #Fibromyalgia. Read more: https://bit.ly/3P8BbAP https://bit.ly/3P8BbAP"  
[X Link](https://x.com/TonixPharma/status/1873772432231952501)  2024-12-30T16:45Z [----] followers, 12.6K engagements


"$TNXP announces further strengthening of commercial leadership team with appointment of Gary Ainsworth as Vice President Market Access an accomplished executive with extensive leadership in market access strategies. Read more about the appointment here: https://bit.ly/4j5mLiN https://bit.ly/4j5mLiN"  
[X Link](https://x.com/TonixPharma/status/1877433179029585992)  2025-01-09T19:12Z [----] followers, 14.1K engagements


"Seth Lederman M.D. CEO of $TNXP recently met with @MarketJane on @NewToTheStreet to discuss TNX-102 SL and #fibromyalia. See the interview here: https://www.youtube.com/watchv=lCI0PAIxv3M https://www.youtube.com/watchv=lCI0PAIxv3M"  
[X Link](https://x.com/TonixPharma/status/1907894207248732441)  2025-04-03T20:33Z [----] followers, [----] engagements


"Seth Lederman M.D. CEO of $TNXP recently met with Sharon Waldrop President and Founder of the Fibromyalgia Association to discuss TNX-102 SL and the overall fibromyalgia treatment paradigm. Watch the interview here: https://www.youtube.com/watchv=_4d2xDN8zeA https://www.youtube.com/watchv=_4d2xDN8zeA"  
[X Link](https://x.com/TonixPharma/status/1915816701289017592)  2025-04-25T17:14Z [----] followers, [----] engagements


"$TNXP announces that Dr. Seth Lederman CEO participated in a fireside chat at A.G.P.s Annual Healthcare Company Showcase. A webcast recording of the presentation can be found here: https://bit.ly/4dByx2g https://bit.ly/4dByx2g"  
[X Link](https://x.com/TonixPharma/status/1925908747773268360)  2025-05-23T13:36Z [----] followers, [----] engagements


"Today $TNXPannounced a poster presentation at the Annual European Congress of Rheumatology (EULAR) [----] being held June 11-14 [----] in Barcelona Spain. Details on the presentation can be found here: https://bit.ly/43tNpfx https://bit.ly/43tNpfx"  
[X Link](https://x.com/TonixPharma/status/1930700934507553180)  2025-06-05T18:59Z [----] followers, [----] engagements


"Yesterday $TNXP announced that Seth Lederman M.D. Chief Executive Officer will present at the BIO International Convention #BIO2025 on Monday June [--] at 5:00 p.m. in Room 153B at the Boston Convention & Exhibition Center. https://bit.ly/3SMOXuT https://bit.ly/3SMOXuT"  
[X Link](https://x.com/TonixPharma/status/1932832146869100740)  2025-06-11T16:07Z [----] followers, [----] engagements


"$TNXP Announces Peer-Reviewed Publication in @Cancer_Cell Journal Highlighting Positive Preclinical Data of mTNX-1700 in Gastric Cancer Animal Models. More info here: http://bit.ly/4exeX7r http://bit.ly/4exeX7r"  
[X Link](https://x.com/TonixPharma/status/1942198883976614020)  2025-07-07T12:27Z [----] followers, [----] engagements


"$TNXP Announces Presentation of Preclinical TNX-801 Safety Immunogenicity and Efficacy Data at theVaccineCongress [----]. More info here: http://bit.ly/3GgfYV6 http://bit.ly/3GgfYV6"  
[X Link](https://x.com/TonixPharma/status/1943731140939939975)  2025-07-11T17:56Z [----] followers, [----] engagements


"#Breaking: The @US_FDA has approved our treatment for #fibromyalgia in adultsthe first FDA-approved therapy in over [--] years. #TonixPharma Learn more: $TNXP https://bit.ly/41aJVwY https://bit.ly/41aJVwY"  
[X Link](https://x.com/TonixPharma/status/1957397737324081622)  2025-08-18T11:02Z [----] followers, 14.9K engagements


"@TonixPharma announced positive Pre-IND feedback from the FDA for TNX-102 SL in Major Depressive Disorder (MDD). An IND filing is expected in Q4 [----] advancing a potential first-in-class treatment designed to address the sleep disturbance associated with depression. Read more here: http://bit.ly/4gxUbWD http://bit.ly/4gxUbWD"  
[X Link](https://x.com/TonixPharma/status/1968686918054387734)  2025-09-18T14:41Z [----] followers, [---] engagements


"Tonix CEO @SethLederman launches his new Substack a forum for science policy & innovation in chronic pain. His first post: Suffering We Can Stop: The cruel choice between pain and addiction 🔗 #ChronicPain #OpioidCrisis #TNXP #Biotech http://bit.ly/48k3iYL http://bit.ly/48k3iYL"  
[X Link](https://x.com/TonixPharma/status/1975554697327988920)  2025-10-07T13:31Z [----] followers, [----] engagements


"PharmaVoice recently highlighted Tonmya the first newly approved fibromyalgia therapy in over [--] years. This milestone reflects the growing importance of advancing non-opioid treatment options for patients living with chronic conditions like fibromyalgia and underscores @TonixPharma commitment to delivering innovative solutions for areas of high unmet need. Read more: https://tinyurl.com/5bk58ypr https://tinyurl.com/5bk58ypr"  
[X Link](https://x.com/TonixPharma/status/1975997074127892992)  2025-10-08T18:49Z [----] followers, [----] engagements


"When waiting hurts. Millions live with post-infectious chronic illnesses like #Fibromyalgia #LongLyme and #LongCOVID. Tonix CEO Dr. Seth Lederman calls for urgent collaboration to accelerate research and relief. Read more: #TonixPharma #IACI #ChronicPain http://bit.ly/4qd2lb5 http://bit.ly/4qd2lb5 http://bit.ly/4qd2lb5 http://bit.ly/4qd2lb5"  
[X Link](https://x.com/TonixPharma/status/1978445177069953392)  2025-10-15T12:57Z [----] followers, [----] engagements


"We are pleased to announce $TNXP will be added to the #MSCI Global Micro Cap Index on May [--] [----]. http://t.co/664yGWwTde @MSCI_Inc http://bit.ly/1tQbJ2d http://bit.ly/1tQbJ2d"  
[X Link](https://x.com/TonixPharma/status/471755290212200448)  2014-05-28T20:50Z [----] followers, [--] engagements


"Maine is facing record Lyme disease cases and new prevention strategies are urgently needed. @newscentermaine featured Tonixs work on a long-acting antibody approach to Lyme prevention with expert insights from CEO @SethLederman. Thank you to @vivienleigh6 for covering this important topic Read more: #LymeDisease #PublicHealth #Biotech https://www.newscentermaine.com/article/news/health/tick-and-lyme/maine-faces-record-lyme-cases-new-antibody-shot-offer-protection-by-2029/97-db405270-3509-472d-89c9-c34327c4a609"  
[X Link](https://x.com/anyuser/status/2021621562441371926)  2026-02-11T16:25Z [----] followers, [---] engagements


"RT @SethLederman: Although it's often used as a punchline Fibromyalgia is very real. I saw its debilitating symptoms firsthand in countles"  
[X Link](https://x.com/anyuser/status/2021264468064215495)  2026-02-10T16:46Z [----] followers, [--] engagements


"Although it's often used as a punchline Fibromyalgia is very real. I saw its debilitating symptoms firsthand in countless patients. Here is my latest article on how science can close the gap on chronic pain: https://sethmlederman.substack.com/p/no-hollywood-ending-howard-hughes https://sethmlederman.substack.com/p/no-hollywood-ending-howard-hughes"  
[X Link](https://x.com/anyuser/status/2021262100157374759)  2026-02-10T16:36Z [---] followers, [---] engagements


"Tonix Pharmaceuticals has opened a new larger corporate headquarters in Berkeley Heights NJ reinforcing our long-term commitment as a commercial-stage biotech company focused on CNS and immunology therapies. Learn more: #Biotechnology #LifeSciences #CommercialStage #NewJersey http://www.tonixpharma.com http://www.tonixpharma.com"  
[X Link](https://x.com/anyuser/status/2019468540428845455)  2026-02-05T17:49Z [----] followers, [----] engagements


"#MichaelJackson's death wasnt just a tragedy it was a failure of how medicine treats chronic pain and sleep disorders. In RealClear Health our CEO @SethLederman examines fibromyalgia fragmented care and why symptom-chasing with risky drugs still persists today. We know better now. Care must change. More essays and reflections are available on Seths Substack: #ChronicPain #Fibromyalgia #SleepHealth #PainScience #NonOpioidCare #Tonix Read article: http://bit.ly/4qWynYR http://bit.ly/4rAbhr3 http://bit.ly/4qWynYR http://bit.ly/4rAbhr3"  
[X Link](https://x.com/anyuser/status/2019468407020699725)  2026-02-05T17:49Z [----] followers, [----] engagements


"On Thursday January [--] at 2:30 PM Gregory Sullivan MD Chief Medical Officer of @TonixPharma will discuss the recently FDA-approved medicine TONMYA a centrally acting non-opioid analgesic for the treatment of fibromyalgia at the Non-Opioid Pain Therapeutics Summit in Boston highlighting key learnings from Phase [--] studies and the role of targeting non-refreshing sleep to address core symptoms. #Fibromyalgia #NonOpioidPain #PainTherapeutics #Biotech #ClinicalResearch"  
[X Link](https://x.com/anyuser/status/2016139907627155806)  2026-01-27T13:23Z [----] followers, [----] engagements


"A productive week in San Francisco for the @TonixPharma team engaging with investors and biotech leaders and sharing the Tonix story. Were heading into [----] energized focused and confident in whats ahead #Tonix #Biotech #Biopharma #HealthcareInnovation #JPMHC2026"  
[X Link](https://x.com/anyuser/status/2013589526489203112)  2026-01-20T12:28Z [----] followers, [----] engagements


"Regulatory modernization will be a defining factor for biopharma in [----]. In PharmaVoices Crystal Ball feature @TonixPharma CEO Dr. Seth Lederman discusses how smarter review pathways and real-world evidence can help move meaningful therapies forward more efficiently. Thank you to @PharmaVoice and @MeaganParrish for the opportunity to contribute. 🔗 #FDA #Biotech #LifeSciences #Innovation https://www.pharmavoice.com/news/pharma-crystal-ball-2026-predictions-regulations-policy-market/808688/ https://www.pharmavoice.com/news/pharma-crystal-ball-2026-predictions-regulations-policy-market/808688/"  
[X Link](https://x.com/anyuser/status/2009611149453447536)  2026-01-09T13:00Z [----] followers, [---] engagements


"@TonixPharma CEO Dr. Seth Lederman will present and host investor meetings at two upcoming conferences in San Francisco. On Sunday January [--] Tonix will present at the Sachs Associates 9th Annual Neuroscience Innovation Forum at 11:55 a.m. PT and participate in the Innovation in Neuropsychiatric Drug Development panel at 1:15 p.m. PT. Dr. Lederman will also present at Biotech Showcase [----] on Tuesday January [--] at 11:00 a.m. PT. Read more here: #Tonix #TNXP #Biotech #Neuroscience #InvestorConferences https://bit.ly/49taPmZ https://bit.ly/49taPmZ"  
[X Link](https://x.com/anyuser/status/2008509836170805657)  2026-01-06T12:03Z [----] followers, [----] engagements


"Were announcing an update on our TNX-4800 program for Lyme disease. Due to the high unmet need and the fact that over [--] million Americans live work and vacation in areas of large tick populations we are exploring new development options including a controlled human infection model (CHIM) and a Phase 2/3 adaptive field study. Read more here: https://bit.ly/4avTb4d https://bit.ly/4avTb4d"  
[X Link](https://x.com/anyuser/status/2005621934478733757)  2025-12-29T12:48Z [----] followers, [---] engagements


"@TonixPharma CEO Dr. Seth Lederman shares his thoughts in a new DC Journal piece on why pain is still a vital sign and why chronic pain patients deserve access to science driven non-opioid solutions. Read more #TonixPharmaceuticals #PainManagement #ChronicPain #NonOpioid #LifeSciences https://dcjournal.com/a-good-idea-that-broke-bad-why-pain-is-still-a-vital-sign/ https://dcjournal.com/a-good-idea-that-broke-bad-why-pain-is-still-a-vital-sign/"  
[X Link](https://x.com/anyuser/status/2001308419232329903)  2025-12-17T15:08Z [----] followers, [---] engagements


"@TonixPharma has just licensed a novel compound from Rutgers University that is designed to treat chronic neuropathic pain. TNX-4900 advances research into non-opioid solutions for chronic pain. The new program reinforces Tonixs commitment to investigating potential new therapies for patients suffering from debilitating pain conditions. Read more here: https://bit.ly/44xsMPI https://bit.ly/44xsMPI"  
[X Link](https://x.com/anyuser/status/2000951776061628544)  2025-12-16T15:30Z [----] followers, [---] engagements


"We are pleased to announce the appointment of Irina Ishak as General Counsel. Ms. Ishak brings more than [--] years of corporate and commercial legal experience advising public and private life sciences companies as well as sector investors. Ms. Ishak will play a key role in guiding our legal strategy as we work to provide innovative medicines to patients with unmet medical needs. Read more here: https://bit.ly/4pqC7B8 https://bit.ly/4pqC7B8"  
[X Link](https://x.com/anyuser/status/1998364860803960971)  2025-12-09T12:11Z [----] followers, [---] engagements


"Were proud to report the FDA has cleared our IND for TNX-102 SL in Major Depressive Disorder. Clinical trials in MDD are scheduled to start in [----]. This milestone reflects our commitment to studying TNX-102 SL in new indications where there is significant unmet medical need. Read more here: https://bit.ly/4polmpL https://bit.ly/4polmpL"  
[X Link](https://x.com/anyuser/status/1992928260053737969)  2025-11-24T12:08Z [----] followers, [----] engagements


"Today we launched the first therapy approved in the US for fibromyalgia in [--] years. We are proud to provide patients a new therapeutic option. Read more here: https://bit.ly/48fcayl https://bit.ly/48fcayl"  
[X Link](https://x.com/anyuser/status/1990456457746133022)  2025-11-17T16:26Z [----] followers, [----] engagements


"Its today Tune in at 10:00 AM ET as Seth Lederman M.D. CEO of Tonix Pharmaceuticals presents at the Stifel [----] Healthcare Conference. Catch the live webcast here: http://bit.ly/4p1RY8G http://bit.ly/4p1RY8G"  
[X Link](https://x.com/anyuser/status/1988934167518933221)  2025-11-13T11:37Z [----] followers, [----] engagements


"Today @TonixPharma announced its Q3 [----] earnings highlighting $190 million in cash as of the end of Q3 with a cash runway into Q1 [----] and strong momentum heading into the end of the year as the company prepares to launch Tonmya the first FDA-approved treatment for fibromyalgia in over [--] years. Tonix is also advancing programs for Lyme disease prevention and kidney transplant rejection underscoring its commitment to innovative science and driving future growth. Read more here: https://tinyurl.com/mrxaam4u https://tinyurl.com/mrxaam4u"  
[X Link](https://x.com/anyuser/status/1987993561573265682)  2025-11-10T21:19Z [----] followers, [----] engagements


"Were heading tothe Stifel [----] Healthcare Conferencethis week. Seth Lederman M.D. CEO of Tonix Pharmaceuticals will present on Thursday November [--] at 10:00 AM ET. Join the live webcast here: https://tinyurl.com/4x4nttwd https://tinyurl.com/4x4nttwd"  
[X Link](https://x.com/anyuser/status/1987961225183912224)  2025-11-10T19:11Z [----] followers, [---] engagements


"@TonixPharma announced a collaboration with Massachusetts General Hospital to advance an investigator-initiated Phase [--] study of TNX-1500 a dimeric Fc-modified anti-CD40L antibody in kidney transplant recipients. The study is expected to begin in the first half of [----] and will evaluate TNX-1500s safety and activity as a potential new monotherapy to reduce conventional immunosuppressive use and improve outcomes. Read more here: https://tinyurl.com/yc4b7pmn https://tinyurl.com/yc4b7pmn"  
[X Link](https://x.com/anyuser/status/1986076502543258055)  2025-11-05T14:21Z [----] followers, [----] engagements


"Gender bias still affects how patients are heard and treated. In his new Substack essay Tonix CEO @SethLedermanMD shares a perspective on closing the care gap through better data awareness and empathy. #HealthEquity #PatientCare #TonixPharma https://bit.ly/4omALXA https://bit.ly/4omALXA"  
[X Link](https://x.com/anyuser/status/1985722267083686057)  2025-11-04T14:54Z [----] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing